Premenstrual Dysphoric Disorder Completed Phase 4 Trials for Sertraline (DB01104)

Also known as: Premenstrual dysphoric disorder

IndicationStatusPhase
DBCOND0005024 (Premenstrual Dysphoric Disorder)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00536198Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric DisorderTreatment